Pro Medicus Share Price and Company Fundamentals
Last traded: Today at 3:43 AM
Pro Medicus Limited, a healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe. The company offers Visage RIS Visage 7 Enterprise Imaging Platform, a healthcare imaging software that provides radiologists, physicians, and clinicians with access and visualization capability for viewing 2-D, 3-D, and 4-D medical images; and picture archive and communication system (PACS)/digital imaging software. It also provides Visage RIS, a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform for secure email and integration products. In addition, the company offers Visage Ease, a mobile application that provides users access to medical imaging results; and Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.
Key Metrics
PE ratio
147.60
PB ratio
66.00
Dividend yield
0.34%
Beta
0.60
Market cap
$16.96B
Enterprise value
$18.34B
Company profile
| Industry / Sector | Health Information Services / Healthcare |
|---|---|
| Full time employees | 132 |
| Website | https://www.promed.com.au |
| Mailing address | 450 Swan Street Richmond VIC 3121 Australia |
| Phone / Fax | 61 3 9429 8800 / 61 3 9429 9455 |
Dividends
More: Pro Medicus Dividend history, yield and payout ratio
Dividend yield
0.34%
Dividend amount
$0.60
Payout ratio
42.69%
5Y Avg. yield
-%
Pro Medicus paid $0.60 dividend and the ex-dividend date was 03 Sep 2025.The dividend payout ratio is 42.69%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.PME dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Pro Medicus.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Dr. Sam Aaron Hupert M.B.B.S., M.D. | Co-Founder, CEO, MD & Executive Director | ||
| Mr. Anthony Barry Hall B.Sc., B.Sc.(Hons), M.Sc. | Co-Founder, Technology Director & Executive Director | ||
| Mr. Clayton James Hatch B.Comm, CPA | Chief Financial Officer | ||
| Dr. Malte Westerhoff Ph.D. | GM of Europe & Global CTO | ||
| Mr. Brad Levin | GM of North America & Global Head of Marketing | ||
| Ms. Sharni L. Redenbach | People & Culture Director | ||
| Mr. Sean Michael Lambright | Global Head of Sales - Visage Imaging Inc | ||
| Ms. Teresa Gschwind | Global Head of Customer Service of Visage Imaging Inc. | ||
| Ms. Danny English C.A. | Financial Controller & Company Secretary |
Profitability and management effectiveness
Profit margin
54.10%
Operating margin
75.88%
Return on assets
33.09%
Return on equity
51.82%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Pro Medicus is 16.96B and its enterprise value is 18.34B. The enterprise value to revenue ratio of PME is 86.11. The enterprise value to EBITDA ratio of PME is 115.99.
The PME's stocks Beta value is 0.60 making it 40% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Pro Medicus (PME)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Polynovo (PNV)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Pro Medicus (ASX:PME) Frequently Asked Questions
1. What is Pro Medicus's Stock Symbol?
Pro Medicus trades on ASX under the ticker symbol "PME".
2. What is Pro Medicus's stock price today?
One share of PME stock can currently be purchased for approximately $162.36.
3. How can I contact Pro Medicus?
Pro Medicus's mailing address is 450 Swan Street Richmond VIC 3121 Australia. The company can be reached via phone at 61 3 9429 8800.
4. What is Pro Medicus's official website?
The official website of Pro Medicus is https://www.promed.com.au.